Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications
Open accessThe DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Abstract
Liposomes are known to be promising nanoparticles (NPs) for drug delivery applications. Among the different types of self-assembled NPs, liposomes stand out for their non-toxic nature and their possession of dual hydrophilic-hydrophobic domains. The advantages of liposomes include the ability to solubilize hydrophobic drugs, the ability to incorporate different hydrophilic and lipophilic drugs at the same time, lessening the exposure of host organs to potentially toxic drugs and allowing modification of the surface by a variety of different chemical groups. This modification of the surface, or of the individual constituents, may be used to achieve two important goals. First, ligands for active targeting can be attached that are recognized by cognate receptors overexpressed on the target cells of tissues. Second, modification can be used to impart a stimulus-responsive or “smart” character to the liposomes, whereby the cargo is released on demand only when certain internal stimuli (pH, reducing agents, specific enzymes) or external stimuli [light, magnetic field, or ultrasound (US)] are present. Here, we review the field of smart liposomes for drug delivery applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Patra, S., Roy, E., Madhuri, R., & Sharma, P. K. (2016) · RSC Advances · doi:10.1039/c6ra14584a · Cited by 14
RetractedOne‐Dimensional Nanostructures: Synthesis, Characterization, and Applications
Xia, Y., Yang, P., Sun, Y., Wu, Y., Mayers, B., Gates, B., Yin, Y., Kim, F., & Yan, H. (2003) · Advanced Materials · doi:10.1002/adma.200390087 · Cited by 8,559 · cited 1×
“) can absorb light in the NIR region and in the visible region (five times higher absorption coefficients than common photo-absorbing dyes) [90].”
BackgroundRecent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · cited 1×
“temperature, light, magnetic field, or ultrasound (US)) [16].”
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Doxil Doxorubicin (DOX) Kaposi’s sarcoma [18, 19] Breast cancer Myocet DOX Metastatic breast cancer [20, 21] Lipodox DOX Breast cancer [22] Kaposi’s sarcoma [23] Ovarian cancer Daunoxome Daunorubicin Kaposi’s sarcoma [24, 25] Marqibo Vincristine Acute lymphoblastic leukemia [26–28] Amphotec Amphotericin B Invasive asp…”
BackgroundDiffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 1×
“[12] reported the first “swollen” phospholipid system that formed distinct layers, and during the following years, a novel drug delivery system (DDS) based on liposomes was developed.”
BackgroundA clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839 · cited 1×
“Electromagnetic light wavelengths below 650 nm cannot penetrate deeply through tissue (>1 cm) because of scattering and absorption by endogenous chromophores (like water, lipids, and hemoglobin) [71]; thus, although UV light can trigger a lot of chemical reactions, it can be employed as a triggering agent only for sup…”
BackgroundLiposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632 · cited 1×
“Among the many different types of NPs, liposomes are one of the most attractive types for use as drug carriers due to their dual hydrophilic-hydrophobic domains [11].”
BackgroundEustis, S., & El-Sayed, M. A. (2006) · Chem. Soc. Rev. · doi:10.1039/b514191e · Cited by 3,143 · cited 1×
“The absorption occurs due to the surface plasmons (quasi-particles of plasma oscillation), whereby the conductance electrons possess a high resonance with certain electromagnetic frequencies [91].”
BackgroundLink, S., & El-Sayed, M. A. (2000) · International Reviews in Physical Chemistry · doi:10.1080/01442350050034180 · Cited by 2,374
Ohkuma, S., & Poole, B. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3327 · Cited by 2,174 · cited 1×
“Moreover, the liposomal carrier and its contents can be totally degraded by various enzymes after its delivery to the lysosomes after endocytosis occurs into target cells (Figure 7) [108].”
Background
Cited by
Liposomes and polymersomes: a comparative review towards cell mimicking
Rideau, E., Dimova, R., Schwille, P., Wurm, F. R., & Landfester, K. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00162f · Cited by 1,105
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · doi:10.20944/preprints201810.0507.v1 · Cited by 605
Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery
Antimisiaris, S. G., Mourtas, S., & Marazioti, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040218 · Cited by 603
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
Stimulus-responsive polymeric nanogels as smart drug delivery systems
Hajebi, S., Rabiee, N., Bagherzadeh, M., Ahmadi, S., Rabiee, M., Roghani-Mamaqani, H., Tahriri, M., Tayebi, L., & Hamblin, M. R. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.05.018 · Cited by 424
Self-citationFarjadian, F., Abbaspour, S., Sadatlu, M. A. A., Mirkiani, S., Ghasemi, A., Hoseini‐Ghahfarokhi, M., Mozaffari, N., Karimi, M., & Hamblin, M. R. (2020) · ChemistrySelect · doi:10.1002/slct.202002501 · Cited by 323
Self-citationLiposomes for Tumor Targeted Therapy: A Review
Wang, S., Chen, Y., Guo, J., & Huang, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032643 · Cited by 315
Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery
Almeida, B., Nag, O. K., Rogers, K. E., & Delehanty, J. B. (2020) · Molecules · doi:10.3390/molecules25235672 · Cited by 298
pH-Responsive Nanocarriers in Cancer Therapy
AlSawaftah, N. M., Awad, N. S., Pitt, W. G., & Husseini, G. A. (2022) · Polymers · doi:10.3390/polym14050936 · Cited by 268
Gajbhiye, K. R., Salve, R., Narwade, M., Sheikh, A., Kesharwani, P., & Gajbhiye, V. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01849-0 · Cited by 262
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Metadata
- Authors
- Zangabad, P. S., Mirkiani, S., Shahsavari, S., Masoudi, B., Masroor, M., Hamed, H., Jafari, Z., Taghipour, Y. D., Hashemi, H., Karimi, M., & Hamblin, M. R.
- Venue
- Nanotechnology Reviews
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-12-12
- Volume
- 7
- Issue
- 1
- Pages
- 95-122
- ISSN
- 2191-9089 (ISSN-L)
- 2191-9097
- OpenAlex
- W2764126552
- Cited by
- 163
- References
- 186
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.